Skip to search formSkip to main contentSkip to account menu

Acute Promyelocytic Leukemia

Known as: Leukemia, Progranulocytic, AML M3, LEUKEMIA, PROMYELOCYTIC 
An acute myeloid leukemia (AML) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
of their disease. Obviously, a randomized double-blind study is a much better design to assess drug efficacy. However, we… 
Review
2003
Review
2003
All-trans-retinoic acid (RA)-based differentiation therapy induces clinical remissions in acute promyelocytic leukemia (APL… 
Review
2002
Review
2002
Our understanding of the hemostatic abnormalities in acute promyelocytic leukemia (APL) has undergone remarkable changes over the… 
Highly Cited
1997
Highly Cited
1997
Until recently, chemotherapy and hematopoietic stem-cell transplantation were the only therapeutic options in acute leukemia. The… 
Highly Cited
1996
Highly Cited
1996
All-trans retinoic acid (t-RA) administration leads to complete remission in acute promyelocytic leukemia (APL) patients by… 
Highly Cited
1995
Highly Cited
1995
Agents that disrupt mitochondrial function were used to monitor the contribution of ATP to cell cycle progression. Following… 
Highly Cited
1992
Highly Cited
1992
The t(15;17) translocation is specifically observed in patients with promyelocytic leukemia (AML3). The chromosomal rearrangement… 
Highly Cited
1981
Highly Cited
1981
The expression of two surface antigens present on the cell membrane of both human granulocytes and monocytes was studied during… 
Highly Cited
1979
Highly Cited
1979
Sixteen patients, 15 adults and one child, with APL have been studied cytogenetically; 14 of these had an abnormal karyotype (87…